Miniaturized proteins: The backbone cyclic proteinomimetic approach

Journal of Molecular Biology

Volumn 292, Issue 2, 1999, Pages 421-429

  Kasher, Ron ^a   Oren, Deena A ^a   Barda, Yaniv ^a   Gilon, Chaim ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Backbone cyclic peptides; Backbone cyclization; Bovine pancreatic trypsin inhibitor; Cycloscan; Proteinomimetic

Indexed keywords

APROTININ; CYCLOPEPTIDE; NONAPEPTIDE; TRYPSIN;

ARTICLE; BINDING KINETICS; CRYSTAL STRUCTURE; CYCLIZATION; ENZYME INHIBITOR COMPLEX; PRIORITY JOURNAL; PROTEIN CONFORMATION;

EID: 0033578941     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.3053     Document Type: Article

References (61)

1. Akaji K., Tatsumi T., Yoshida M., Kimura T., Fujiwara Y., Kiso Y. Synthesis of cystine-peptide by a new disulphide bond-forming reaction using the silyl chloride-sulphoxide system. J. Chem. Soc. Chem. Commun. 1991;167-168.
2. Akaji K., Tatsumi T., Yoshida M., Kimura T., Fujiwara Y., Kiso Y. Disulfide bond formation using the silyl chloride-sulfoxide system for the synthesis of a cystine peptide. J. Am. Chem. Soc. 114:1992;4137-4143.
3. Akerfeldt K. S., Kim R. M., Camac D., Groves J. T., Lear J. D., DeGrado W. F. Tetraphilin: A four helix proton channel built on a tetraphenylporphyrin framework. J. Am. Chem. Soc. 114:1992;9656-9657.
4. α-functionalized alkylamino acids by reductive alkylation of natural amino acids. J. Chem. Soc., Perkin Trans. I:1997;1501-1510.
5. Bode W., Huber R. Natural protein proteinase inhibitors and their interaction with proteinases. Annu. Rev. Biochem. 204:1992;433-451.
6. Braisted A. C., Wells J. A. Minimizing a binding domain from protein A. Proc. Natl Acad. Sci. USA. 93:1996;5688-5692.
7. Brunger A. T. X-PLOR Manual, Version 3.1. 1992;Yale University, New Haven.
8. Bryson J. W., Betz S. F., Lu H. S., Suich D. J., Zhou H., O'Neil K. T., DeGrado W. F. Protein design: a hierarchic approach. Science. 270:1995;935-941.
9. Byk G., Halle D., Zeltser I., Bitan G., Selinger Z., Gilon C. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of Substance P. J. Med. Chem. 39:1996;3174-3178.
10. Chen Z., Bode W. Refined 2.5 Å X-ray crystal structure of the complex formed by porcine kallikrein A and the bovine pancreatic trypsin inhibitor. J. Mol. Biol. 164:1983;283-311.
11. Choma C. T., Lear J. D., Nelson M. J., Dutton P. L., Robertson D. E., DeGrado W. F. Design of a heme-binding four-helix bundle. J. Am. Chem. Soc. 116:1994;856-865.
12. Choo Y., Sanchez-Garcia I., Klug A. In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence. Nature. 372:1994;642-645.
13. Acta Crystallog. sect. D. 50:1994;760-763.
14. Corey D. R., Philips M. A. Cyclic peptides as proteases. Proc. Natl Acad. Sci. USA. 91:1994;4106-4109.
15. Corey M. J., Corey E. On the failure of de novo -designed peptides as biocatalysts. Proc. Natl Acad. Sci. USA. 93:1996;11428-11434.
16. Cunningham B. C., Wells J. A. Minimized proteins. Eng. Design. 1997;457-462.
17. Dahiyat B. I., Mayo S. L. De novo protein design: fully automated sequence selection. Science. 278:1997;82-87.
18. Dahiyat B. I., Sarisky C. A., Mayo S. L. De novo protein design: towards fully automated sequence selection. J. Mol. Biol. 273:1997;789-796.
19. DeGrado W. F., Wasserman Z. R., Lear J. D. Protein design, a minimalist approach. Science. 243:1989;622-628.
20. Deisenhofer J., Steigemann W. Crystallographic refinement of the structure of bovine pancreatic trypsin inhibitor at 1.5 Å resolution. Acta Crystallog. sect. B. 31:1975;238-250.
21. Domingo G. J., Leatherbarrow R. J., Freeman N., Patel S., Weir M. Synthesis of a mixture of cyclic peptides based on the Bowman-Birk reactive site loop to screen for serine protease inhibitors. Int. J. Peptide Protein Res. 46:1995;79-87.
22. Eichler J., Houghten R. A. Identification of substrate-analog trypsin inhibitors through the screening of synthetic peptide combinatorial libraries. Biochemistry. 32:1993;11035-11041.
23. Fairlie D. P., West M. L., Wong A. K. Towards protein surface mimetics. Curr. Med. Chem. 5:1998;29-62.
24. Friedler A., Zakai N., Karni O., Broder Y. C., Baraz L., Loyter A., Kotler M., Gilon C. Backbone cyclic peptide which mimics the nuclear import of HIV-1 matrix protein inhibits nuclear import and virus reproduction in non-dividing cells. Biochemistry. 37:1998;5616-5622.
25. Fujii N., Otaka A., Ikemura O., Akaji K., Funakoshi S., Hayashi Y., Kuroda Y., Yajima H. Trimethylsilyl trifluoromethanesulphonate as a useful deprotecting reagent in both solution and solid phase peptide synthesis. J. Chem. Soc. Chem. Commun. 1987;274-275.
26. Gebhard W., Tschesche H., Fritz H. Biochemistry of aprotinin and aprotinin-like inhibitors. Barrett A. J., Salvesen G. Proteinase Inhibitors. 1986;375-389 Elsevier Science, Amsterdam.
27. Geiger R., Fritz H. Trypsin. Fritz H. Peptidases, Proteinases and their Inhibitors. 1984;119-127 Verlag-Chemie, Weinheim.
28. Gilon C., Halle D., Chorev M., Selinger Z., Byk G. Backbone cyclization: a new method for conferring conformational constraint on peptides. Biopolymers. 31:1991;745-750.
29. Gilon C., Muller D., Bitan G., Salitra Y., Goldwasser I., Hornik V. 24th Conference of the European Peptide Society. 1998.
30. Hecht M. H., Richardson J. S., Richardson D. C., Ogden R. C. De novo design, expression and characterization of Felix: A four-helix bundle protein of native-like sequence. Science. 249:1990;884-891.
31. Houghten R. General method for the rapid solid-phase synthesis of large numbers of peptides: Specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl Acad. Sci. USA. 82:1985;5131-5135.
32. Huang Q., Liu S., Tang Y. Refined 1.6 Å resolution crystal structure of the complex formed between porcine β-trypsin and MCTI-A, a trypsin inhibitor of the squash family. J. Mol. Biol. 229:1993;1022-1036.
33. Huber R., Bode W. Structural basis of the activation and action of trypsin. Accts. Chem. Res. 11:1978;114-122.
34. Jancarik J., Kim S. H. Sparce matrix sampling: a screening method for crystallization of proteins. J. Appl. Crystallog. 24:1991;409-411.
35. Janin J., Chothia C. Stability and specificity of protein-protein interactions: The case of the trypsin-trypsin inhibitor complexes. J. Mol. Biol. 100:1976;197-211.
36. Jones L. J., Upson R. H., Haugland R. P., Panchuk-Voloshina N., Zhou M., Haugland R. P. Quenched BODIPY dye-labeled casein substrates for the assay of protease activity by direct fluorescence measurement. Anal. Biochem. 251:1997;144-152.
37. Jones T. A. Interactive computer graphics: FRODO. Methods Enzymol. 115:1985;157-171.
38. Kamber B., Hartmann A., Eisler K., Riniker B., Rink H., Sieber P., Rittel W. The synthesis of cystine peptides by iodine oxidation of S-trityl-cysteine and S-acetamidomethyl-cysteine peptides. Helv. Chim. Acta. 63:1980;899-915.
39. 38. Letters Peptide Sci. 5:1998;101-103.
40. Knight C. G. The characterization of enzyme inhibition. Barrett A. J., Salvesen G. Proteinase Inhibitors. 1986;23-51 Elsevier, Amsterdam.
41. Kortemme T., Ramirez-Alvarado M., Serrano L. Design of a 20-amino acid, three stranded β-sheet protein. Science. 281:1998;253-256.
42. Laskowski M. Jr, Kato I. Protein inhibitors of proteinases. Annu. Rev. Biochem. 49:1980;593-626.
43. Leatherbarrow R. J., Salacinski H. J. Design of a small peptide-based proteinase inhibitor by modeling the active-site region of barley chymotrypsin inhibitor 2. Biochemistry. 30:1991;10717-10721.
44. Maeder D., Sunde M., Botes D. P. Design and inhibitory properties of synthetic Bowman-Birk loops. Int. J. Peptide Protein Res. 40:1992;97-102.
45. Marquart M., Walter J., Deisenhofer J., Bode W., Huber R. The geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors. Acta Crystallog. sect. B. 39:1983;480-490.
46. Matthews B. W., Craik C. S., Neurath H. Can small peptides have the activity and specificity of proteolytic enzymes? Proc. Natl Acad. Sci. USA. 91:1994;4103-4105.
47. α-(ω-aminoalkyl)amino acids. J. Org. Chem. 62:1997;411-416.
48. Mutter M., Vuilleumier S. A chemical approach to protein design- Template-Assembled Synthetic Proteins (TASP). Angew. Chem. Int. Ed. Eng. 28:1989;535-676.
49. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1996;307-325.
50. Ozawa K., Laskowski M. Jr. The reactive site of trypsin inhibitors. J. Biol. Chem. 241:1966;3955-3961.
51. Quinn T. P., Tweedy N. B., Williams R. W., Richardson J. S., Richardson D. C. Betadoublet: De novo design, synthesis and characterization of a β-sandwich protein. Proc. Natl Acad. Sci. USA. 91:1994;8747-8751.
52. Regan L. Protein design: novel metal-binding sites. Trends Biochem. Sci. 20:1995;280-285.
53. Ruhlmann A., Kukla D., Schwager P., Bartels K., Huber R. Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact residues. J. Mol. Biol. 77:1973;417-436.
54. Schafmeister C. E., LaPorte S. L., Miercke L. J. W., Stroud R. M. A designed four helix bundle protein with native-like structure. Nature Struct. Biol. 4:1997;1039-1046.
55. Segel I. H. Enzyme Kinetics. 1975;John Wiley & Sons, New York. p. 161-226.
56. Struthers M. D., Cheng R. P., Imperiali B. Design of a monomeric 23-residue polypeptide with defined tertiary structure. Science. 271:1996;342-345.
57. Tan N. H., Kaiser E. T. Synthesis and characterization of a pancreatic trypsin inhibitor homologue and a model inhibitor. Biochemistry. 16:1977;1531-1541.
58. Vincent J. P., Lazdunski M. Trypsin-pancreatic trypsin inhibitor association. Dynamics of the interaction and role of disulfide bridges. Biochemistry. 11:1972;2967-2977.
59. Wells J. A., Fairbrother W. J., Otlewski J., Laskowski M. Jr, Burnier J. A reinvestigation of synthetic peptide (TrPepz) designed to mimic trypsin. Proc. Natl Acad. Sci. USA. 91:1994;4110-4114.
60. Wrighton N. C., Farrell F. X., Chang R., Kashyap A. K., Barbone F. P., Mulcahy L. S., Johnson D. L., Barrett R. W., Jolliffe L. K., Dower W. J. Small peptides as potent mimetics of the protein hormone erythropoietin. Science. 273:1996;458-463.
61. Yanofsky S. D., Baldwin D. N., Butler J. H., Holden F. R., Jacobs J. W., Balasubramanian P., Chinn J. P., Cwirla S. E., Peters-Bhatt E., Whitehorn E. A., Tate E. H., Akeson A., Bowlin T. L., Dower W. J., Barrett R. W. High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries. Proc. Natl Acad. Sci. USA. 93:1996;7381-7386.